June 9 (Reuters) - British drugmaker GSK on Tuesday agreed to acquire U.S.-listed cancer drug developer Nuvalent for $10.6 billion to boost its lung cancer portfolio. The all-cash deal values Nuvalent ...
The night began with frustration and boos, and not because of the Knicks. But by the end of Game 3 of the N.B.A. finals, the ...
Rescuers searched ruined buildings in the southern Philippines on Tuesday to ensure no one was still trapped a day after one ...
The U.S. on Monday added Chinese e-commerce giant Alibaba , internet search provider Baidu and automaker BYD to a list of ...
Even the New York Post got in on the fun.
The brother of the 21-year-old Plymouth State University student found dead in a Thornton home Monday has been arrested, ...
It’s been more than two months since President Donald Trump announced a ceasefire with Iran, saying at the time that the two ...
2hon MSN
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and ...
Nithya Raman will advance to the November election in the Los Angeles mayoral race, CNN’s Decision Desk projects, after ...
Three years after Ariana Grande and "Wicked" costar Ethan Slater got off to a rocky start with divorces from exes, their ...
The drone, which entered Latvia from Russia, was the latest to violate the airspace of a NATO member during the war.
A presidential historian says the president loves the attention, both in the arena and, especially, when millions of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results